Chemogenetic profiling identifies RAD17 as synthetically lethal with checkpoint kinase inhibition.
Shen JP, Srivas R, Gross A, Li J, Jaehnig EJ, Sun SM, Bojorquez-Gomez A, Licon K, Sivaganesh V, Xu JL, Klepper K, Yeerna H, Pekin D, Qiu CP, van Attikum H, Sobol RW, Ideker T.
Shen JP, et al. Among authors: ideker t.
Oncotarget. 2015 Nov 3;6(34):35755-69. doi: 10.18632/oncotarget.5928.
Oncotarget. 2015.
PMID: 26437225
Free PMC article.